1 Min Read
April 2 (Reuters) - ARAB DRUG COMPANY FOR PHARMACEUTICALS AND CHEMICAL INDUSTRIES:
* SEES FY 2018-19 NET PROFIT BEFORE TAX EGP 50 MILLION, SALES EGP 400 MLN Source:(bit.ly/2uHHUvm) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.